Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002028420 | SCV002282205 | uncertain significance | Sphingolipid activator protein 1 deficiency | 2021-08-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004045484 | SCV005012019 | uncertain significance | Inborn genetic diseases | 2023-11-18 | criteria provided, single submitter | clinical testing | The c.743A>G (p.Y248C) alteration is located in exon 7 (coding exon 7) of the PSAP gene. This alteration results from a A to G substitution at nucleotide position 743, causing the tyrosine (Y) at amino acid position 248 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |